US Pharmacopeia Announces 2013-2014 Global Fellowships - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

US Pharmacopeia Announces 2013-2014 Global Fellowships



Recognized for establishing quality standards for medicines, food ingredients, and dietary supplements, the United States Pharmacopeial Convention (USP) announced the selection of its 2013-2014 USP Global Fellows. The Global Fellowship program has awarded $150,000 in research grants to support the work of early-career scientists with the goal of advancing research priorities in small moleculedrugs, biologics, excipients, dietary supplements, and food ingredients that address specific USP scientific or research needs.

Each year, USP conducts a competitive process for selecting fellows who are engaged in full-time study in a PhD or Pharm. D. program, medical school, or dental school, and whose works are directly relevant to USP’s priorities.

For the 2013-2014 academic year, three $50,000 USP Global Fellowship awards have been presented to the following students:

• Adam L. Kaylor, PhD candidate, Georgia Institute of Technology, School of Chemistry and Biochemistry

Area of Research—Development of a new pulsed plasma ion source for counterfeit drug analyses by portable ion-mobility spectrometry and rapid liquid chromatography-mass spectrometry (LC-MS).

• Haichen Nie, M.S., Purdue University, College of Pharmacy, Department of Industrial and Physical Pharmacy

Area of Research—Sustainable medicines for Africa—Development of monographs and associated knowledge to increase access to HIV/AIDS medicines for resistant infections (Darunavir-Ritonavir).

• Sharla M. Peters, Postdoctoral candidate, Howard University, College of Medicine, Department of Biochemistry and Molecular Biology

Area of Research—Development of a multiplex real-time polymerase chain reaction assay for the detection of ruminant material in adulterated products.

Each of the Global Fellows will communicate regularly with a scientific liaison from USP headquarters in Rockville, Maryland, providing updates on his or her work and the relevance of its progress to USP’s priorities. In addition, each fellow will be invited to give a poster presentation at an USP-sponsored meeting or event during the course of the academic year.

Source: USP

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here